MedTrace Logo

Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism

NCT02235194 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-24

No results posted yet for this study

Summary

It has previously been shown in healthy overweight subjects, that table water including a defined amount of amino acids and chromium can decrease the postprandial glucose and insulin response. In this study, the effect of this table water on glucose excursions after a test meal containing a defined amount of available carbohydrates, protein and fat will be studied in patients with early type 2 diabetes or prediabetes according to guidelines that are treated with dietary measures or metformin only. The study will be conducted in a cross -over design, double blinded and placebo controlled including 20 participants. The primary endpoint of the study is the incremental area under the curve for plasma glucose (iAUCgluc) within 180 minutes after ingestion of the meal.

Conditions

Interventions

DIETARY_SUPPLEMENT

Amino Acid and chromium-picolinate containing drink

Amino Acid and chromium - picolinate containg water ist taken with a test meal to study efects on glucose and insulin response.

DIETARY_SUPPLEMENT

Placebo Drink

Placebo drink ist taken with a test meal to study efects on glucose and insulin response.

Sponsors & Collaborators

  • Stoffwechselzentrum Rhein - Pfalz

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02235194 on ClinicalTrials.gov